DE2225071A1 - Verfahren zur Herstellung von heterocyclischen Verbindungen und deren Verwendung - Google Patents

Verfahren zur Herstellung von heterocyclischen Verbindungen und deren Verwendung

Info

Publication number
DE2225071A1
DE2225071A1 DE19722225071 DE2225071A DE2225071A1 DE 2225071 A1 DE2225071 A1 DE 2225071A1 DE 19722225071 DE19722225071 DE 19722225071 DE 2225071 A DE2225071 A DE 2225071A DE 2225071 A1 DE2225071 A1 DE 2225071A1
Authority
DE
Germany
Prior art keywords
isothiocyano
group
alkyl
substituents
amino groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19722225071
Other languages
German (de)
English (en)
Inventor
Paul Dr. Basel; Wenger Thomas Dr. Riehen; Gallay Jean-Jacques Dr. Mägden; Schmid Wolfgang Therwil; Brenneisen (Schweiz)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of DE2225071A1 publication Critical patent/DE2225071A1/de
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/70Sulfur atoms
    • C07D277/74Sulfur atoms substituted by carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19722225071 1971-05-24 1972-05-23 Verfahren zur Herstellung von heterocyclischen Verbindungen und deren Verwendung Pending DE2225071A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH754271 1971-05-24

Publications (1)

Publication Number Publication Date
DE2225071A1 true DE2225071A1 (de) 1972-12-07

Family

ID=4326772

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19722225071 Pending DE2225071A1 (de) 1971-05-24 1972-05-23 Verfahren zur Herstellung von heterocyclischen Verbindungen und deren Verwendung

Country Status (9)

Country Link
US (1) US3840550A (OSRAM)
BE (1) BE783791A (OSRAM)
BR (1) BR7203298D0 (OSRAM)
DD (1) DD98517A5 (OSRAM)
DE (1) DE2225071A1 (OSRAM)
FR (1) FR2138884A1 (OSRAM)
IL (1) IL39501A0 (OSRAM)
NL (1) NL7206929A (OSRAM)
ZA (1) ZA723514B (OSRAM)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815621A1 (de) * 1977-04-12 1978-10-19 Ciba Geigy Ag Anthelmintika
US4568674A (en) * 1984-02-15 1986-02-04 Bayer Aktiengesellschaft Anti-coccidal agents 1-[4-(benzothia- or -oxazol-2-ylthio- or -2-yloxy)phenyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione derivatives, compositions, and method of use thereof
EP0192180A1 (de) * 1985-02-15 1986-08-27 Ciba-Geigy Ag 5-(Azolyloxyphenylcarbamoyl)barbitursäure-derivate als Wirkstoffe für Anthelmintika

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933841A (en) * 1971-05-24 1976-01-20 Ciba-Geigy Corporation 2-Phenoxy, -phenylthio-, and -phenyl-amino-benzoxazoles having an isothiocyano substituent
US3969351A (en) * 1974-05-17 1976-07-13 E. R. Squibb & Sons, Inc. Morpholine containing isothiocyanobenzoxazoles
US3915986A (en) * 1974-06-19 1975-10-28 Smithkline Corp Methyl 5-propylthio-2-benzimidazolecarbamate
DE2640730C2 (de) * 1976-09-10 1983-08-25 Hoechst Ag, 6230 Frankfurt Benzoxazolyloxy- und Benzothiazolyloxy-phenoxy-Verbindungen und diese enthaltende herbizide Mittel
DE2913527A1 (de) * 1979-04-04 1980-10-16 Bayer Ag Schaedlingsbekaempfungsmittel
EP0204215B1 (en) * 1985-05-24 1993-08-11 G.D. Searle & Co. 2-[(1H-benzimidazol-2-ylsulfinyl)methyl]-benzenamines
AU2002221902B2 (en) * 2000-12-06 2006-11-23 F. Hoffmann-La Roche Ag Fused heteroaromatic glucokinase activators

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815621A1 (de) * 1977-04-12 1978-10-19 Ciba Geigy Ag Anthelmintika
US4568674A (en) * 1984-02-15 1986-02-04 Bayer Aktiengesellschaft Anti-coccidal agents 1-[4-(benzothia- or -oxazol-2-ylthio- or -2-yloxy)phenyl]-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione derivatives, compositions, and method of use thereof
US4611060A (en) * 1984-02-15 1986-09-09 Bayer Aktiengesellschaft Intermediate(1,3-benzothiazol-2H-yl or 1,3-benzoxazol-2H-yl)4-oxy-or 4-thio-phenylurea derivatives
EP0192180A1 (de) * 1985-02-15 1986-08-27 Ciba-Geigy Ag 5-(Azolyloxyphenylcarbamoyl)barbitursäure-derivate als Wirkstoffe für Anthelmintika
US4762830A (en) * 1985-02-15 1988-08-09 Ciba-Geigy Corporation 5-(azolyloxyphenylcarbamoyl)barbituric acid derivatives as anthelmintics

Also Published As

Publication number Publication date
BE783791A (fr) 1972-11-23
ZA723514B (en) 1973-03-28
US3840550A (en) 1974-10-08
NL7206929A (OSRAM) 1972-11-28
DD98517A5 (OSRAM) 1973-06-20
BR7203298D0 (pt) 1974-08-29
FR2138884A1 (OSRAM) 1973-01-05
IL39501A0 (en) 1972-08-30

Similar Documents

Publication Publication Date Title
DE1770981A1 (de) Neue Isothiocyano-benzazol-Derivate und Verfahren zu deren Herstellung
DE2815621C2 (OSRAM)
DE2259220A1 (de) Kondensationsprodukte und ihre anwendung
CH616157A5 (OSRAM)
DE2225071A1 (de) Verfahren zur Herstellung von heterocyclischen Verbindungen und deren Verwendung
DE2441202C2 (de) 2-Carbalkoxyamino-benzimidazolyl-5(6)-sulfonsäure-phenylester, Verfahren zu ihrer Herstellung und diese enthaltende anthelmintische Mittel
DE2815675A1 (de) Anthelmintika
US3987181A (en) Certain 2-trifluoromethylbenzimidazoles as anthelmintics
DE2800740A1 (de) Anthelmintika
DE1935338C2 (de) Isothiocyano-diphenylamine, Verfahren zu deren Herstellung und ein diese Verbindungen enthaltendes anthelminthisches Mittel
US3822356A (en) Use of isothiocyanobenzoxazoles and isothiocyanobenzimidazoles as anthelmintics
DE3133887A1 (de) 2-arylhydrazino-2-imidazoline, deren acylderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung von endo- und ektoparasiten
US3894037A (en) Certain isothiocyanobenzimidazoles
EP0041046A1 (de) Benzazolderivate, Verfahren zu ihrer Herstellung, diese enthaltende pharmazeutische Präparate und ihre Verwendung
AT281815B (de) Verfahren zur Herstellung von neuen Isothiocyano-benzimidazol- und-benzoxzolderivaten und ihren Salzen
EP0007616B1 (de) Isothiocyanobenzthiazolderivat, Verfahren zu seiner Herstellung und seine Anwendung in anthelmintischen Mitteln
US3933841A (en) 2-Phenoxy, -phenylthio-, and -phenyl-amino-benzoxazoles having an isothiocyano substituent
AT301540B (de) Verfahren zur Herstellung neuer 4-(Isothiocyanophenyl)-thiazole und ihrer Salze
DE2258279A1 (de) Kondensationsprodukte und ihre anwendung
CH540281A (de) Verfahren zur Herstellung von neuen 4-(Isothiocyanatophenyl)-thiazolen
DE1117586B (de) Verfahren zur Herstellung von 2-Amino-3-mercapto-chinoxalinen
DE2630847A1 (de) Methoxycarbonyl-phenyl-guanidine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
AT286292B (de) Verfahren zur Herstellung von neuen Isothiocyano-benzimidazol- und -benzoxazolderivaten und ihren Salzen
CH565164A5 (en) Isocyanato-benzoxazoles-benzothiazoles and benimidazoles - as anthelmintics and antimicrobials
DE1568021C3 (de) Neue Isothiocyano diphenylather und diphenylthioather, deren Herstel lung und Mittel zur Bekämpfung parsi tarer Helminthen und zur Verhütung von Helminthiasen bei Mensch und Tier